However, inactivation of PERK sensitizes cancer cells to a broad spectrum of chemotherapy drugs [177–182], whereas knockdown of PERK in MM cells results in an autophagic type of cell death [182]. The gene discussed is EIF2AK3; the disease is Miyoshi myopathy.